blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0659425

EP0659425 - 2-Phenyl-3-azoylbenzothiophenes for increasing macrophage function [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  11.10.2002
Database last updated on 03.10.2024
Most recent event   Tooltip11.10.2002Application deemed to be withdrawnpublished on 27.11.2002  [2002/48]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [1995/26]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285 / US
Inventor(s)01 / Zuckerman, Steven Harold
7710 Wawasee Drive
Indianapolis, Indiana 46250 / US
[1995/26]
Representative(s)Vaughan, Jennifer Ann, et al
Eli Lilly and Company Limited
Lilly Research Centre
Erl Wood Manor
Windlesham, Surrey GU20 6PH / GB
[N/P]
Former [2002/17]Vaughan, Jennifer Ann, et al
Eli Lilly and Company Limited European Patent Operations Erl Wood Manor
Windlesham, Surrey GU20 6PH / GB
Former [1995/32]Tapping, Kenneth George, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor
Windlesham Surrey GU20 6PH / GB
Former [1995/26]Tapping, Kenneth George
Lilly Industries Limited European Patent Operations Erl Wood Manor
Windlesham Surrey GU20 6PH / GB
Application number, filing date94309483.919.12.1994
[1995/26]
Priority number, dateUS1993017060521.12.1993         Original published format: US 170605
[1995/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0659425
Date:28.06.1995
Language:EN
[1995/26]
Search report(s)(Supplementary) European search report - dispatched on:EP18.04.1995
ClassificationIPC:A61K31/445, A61K31/40, A61K31/38, A61P37/04
[2001/44]
CPC:
A61K31/40 (EP,US); A61K31/4535 (KR); A61K31/38 (EP,US);
A61K31/4025 (KR); A61K31/445 (EP,US); A61P37/04 (EP);
A61P43/00 (EP); A61K31/55 (KR); C07D409/10 (KR) (-)
Former IPC [1995/26]A61K31/445, A61K31/40, A61K31/38
Designated contracting statesAT,   BE,   CH,   DK,   GR,   IE,   LI,   LU,   NL,   PT,   SE [2002/13]
Former [1995/26]AT,  BE,  CH,  DE,  DK,  ES,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  NL,  PT,  SE 
Extension statesLT02.01.1995
SI02.01.1995
TitleGerman:2-Phenyl-3-Azoylbenzothiophene zur Erhöhung der makrophagen Funktion[1995/26]
English:2-Phenyl-3-azoylbenzothiophenes for increasing macrophage function[1995/26]
French:2-Phényl-3-azoylbenzothiophènes pour augmenter la fonction des macrophages[1995/26]
Examination procedure02.01.1995Examination requested  [1995/26]
24.03.2000Despatch of a communication from the examining division (Time limit: M06)
01.09.2000Reply to a communication from the examining division
26.10.2001Despatch of communication of intention to grant (Approval: Yes)
11.02.2002Communication of intention to grant the patent
22.06.2002Application deemed to be withdrawn, date of legal effect  [2002/48]
25.06.2002Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2002/48]
Fees paidRenewal fee
28.10.1996Renewal fee patent year 03
31.10.1997Renewal fee patent year 04
29.10.1998Renewal fee patent year 05
29.11.1999Renewal fee patent year 06
07.12.2000Renewal fee patent year 07
07.12.2001Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DA]US4133814  (JONES C DAVID, et al) [DA] 1-6* column A; claim - *;
 [DA]US4418068  (JONES CHARLES D [US]) [DA] 1-6 * column A; claim - *;
 [A]EP0222385  (JAPAN RES DEV CORP [JP], et al) [A] 1-6 * column W *;
 [A]US5075321  (SCHREIBER ALAN D [US]) [A] 1-6 * column W *
 [A]  - M.C. SANDERS ET AL., "HORMONAL MODULATION OF MACROPHAGE CLEARANCE OF IgG-SENSITIZED CELLS", TRANS. ASSOC. AM. PHYSICIANS, vol. 100, pages 268 - 275 [A] 1-6 * the whole document *
 [A]  - S.A. AHMED ET AL., "SEX HORMONES AND THE IMMUNE SYSTEM", BAILLIERE'S CLINICAL RHEUMATOLOGY, vol. 4, no. 1, pages 13 - 31 [A] 1-6 * summary pages 26-27 *; page 25 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.